Considerations for medical nutrition therapy management of the critically ill patient with hematological malignancies: A narrative review

Juan Carlos Lopez‐Delgado,Jayshil J. Patel,Christian Stoppe,Stephen A. McClave
DOI: https://doi.org/10.1002/ncp.11152
2024-04-28
Nutrition in Clinical Practice
Abstract:Patients with hematological malignancies (HMs) are more frequently admitted now than in the past to the intensive care unit (ICU) due to more aggressive approaches in primary therapy of HMs and the need for critical care support. Pathophysiological alterations derived from HMs and the different hematological therapies, such as chemotherapy, negatively affect gastrointestinal (GI) function, metabolism, and nutrition status. Further, malnutrition strongly influences outcomes and tolerance of the different hematological therapies. In consequence, these critically ill patients frequently present with malnutrition and pathophysiological alterations that create challenges for the delivery of medical nutrition therapy (MNT) in the ICU. Frequent screening, gauging tolerance, and monitoring nutrition status are mandatory to provide individualized MNT and achieve nutrition objectives. The present review discusses how HM impact GI function and nutrition status, the importance of MNT in patients with HM, and specific considerations for guidance in providing adequate MNT to these patients when admitted to the ICU.
nutrition & dietetics
What problem does this paper attempt to address?